| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3625861 | B | Inhibition of muscarinic receptor (unknown origin) | Homo sapiens | 4 | assay format | Scientific Literature | ||
| 2. | ALA3625862 | B | Inhibition of dopamine receptor (unknown origin) | Homo sapiens | 4 | protein format | Scientific Literature | ||
| 3. | ALA3625863 | B | Inhibition of serotonin receptor (unknown origin) | Homo sapiens | 4 | assay format | Scientific Literature | ||
| 4. | ALA3625864 | B | Inhibition of histamine receptor (unknown origin) | Homo sapiens | 4 | assay format | Scientific Literature | ||
| 5. | ALA3625866 | T | Toxicity in Trypanosoma brucei brucei S427 infected NMRI mouse model of stage-1 human African trypanosomiasis assessed as induction if clinical signs of toxicity at 15 mg/kg, ip bid for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA3625869 | F | Antitrypanosomal activity against Trypanosoma brucei brucei BSF427 VSG118 bloodstream forms incubated for 69 hrs by resazurin dye based assay | Trypanosoma brucei brucei | 53 | organism-based format | Scientific Literature | ||
| 7. | ALA3625870 | A | Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 69 hrs by resazurin dye based assay | Homo sapiens | 53 | cell-based format | Scientific Literature | ||
| 8. | ALA3625871 | A | Intrinsic clearance in CD1 mouse liver microsomes incubated for 3 to 30 mins in presence of NADPH by UPLC/MS/MS method | Mus musculus | 45 | assay format | Scientific Literature | ||
| 9. | ALA3625873 | A | Intrinsic clearance in pooled mixed gender human liver microsomes incubated for 3 to 30 mins in presence of NADPH by UPLC/MS/MS method | Homo sapiens | 29 | assay format | Scientific Literature | ||
| 10. | ALA3625874 | T | Selectivity index, ratio of EC50 for cytotoxicty against human MRC5 cells to EC50 for antitrypanosomal activity against Trypanosoma brucei brucei BSF427 VSG118 bloodstream forms | 5 | cell-based format | Scientific Literature | |||
| 11. | ALA3625875 | P | Solubility of the compound | 5 | small-molecule physicochemical format | Scientific Literature | |||
| 12. | ALA3625877 | A | Fraction unbound in rat plasma | Rattus norvegicus | 1 | cell-free format | Scientific Literature | ||
| 13. | ALA3625878 | A | Fraction unbound in NMRI mouse brain at 0.5 to 1 free base/kg, iv by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 14. | ALA3626003 | A | Cmax in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 15. | ALA3626004 | A | Tmax in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 16. | ALA3626005 | A | AUC (0 to 8 hrs) in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 17. | ALA3626006 | A | Half life in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 18. | ALA3626007 | A | Ratio of drug level in brain to blood in NMRI mouse at 0.5 and 1 mg free base/kg, iv after 5 mins by UPLC/MS/MS method | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 19. | ALA3626008 | A | Cmax in NMRI mouse at 10 mg free base/kg, po by UPLC/MS/MS method | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 20. | ALA3626009 | A | Tmax in NMRI mouse at 10 mg free base/kg, po by UPLC/MS/MS method | Mus musculus | 4 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!